ZYDUSLIFE1,118.50

Zydus Lifesciences Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYCIPLATORNTPHARMDIVISLABMAXHEALTHAPOLLOHOSPAUROPHARMAMcap ₹1.13L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment5,803.36,042.09,230.79,230.7
+ Capital Work-in-Progress1,111.51,317.91,165.71,165.7
+ Goodwill5,266.05,242.17,542.77,542.7
+ Other Intangibles1,299.21,849.67,332.47,332.4
+ Intangibles under Development1,311.81,374.02,532.82,532.8
+ Investments (Equity Method)416.21,143.11,166.61,166.6
+ Non-current Investments551.8413.6597.5597.5
+ Long-term Loans0.00.00.20.2
+ Other Non-current Financial Assets178.540.934.434.4
Non-current Financial Assets730.3454.5632.1632.1
+ Deferred Tax Assets1,644.22,343.82,108.62,108.6
+ Other Non-current Assets196.9388.6788.9788.9
Total Non-current Assets17,779.420,155.632,500.532,500.5
Current Assets
+ Inventories3,441.93,944.05,628.15,628.1
+ Current Investments252.54,851.15,775.85,775.8
+ Trade Receivables5,220.24,024.75,415.75,415.7
+ Cash & Cash Equivalents413.0826.8855.2855.2
+ Other Bank Balances692.12,130.0561.4561.4
+ Short-term Loans1.577.13.73.7
+ Other Current Financial Assets657.3513.0216.9216.9
Current Financial Assets7,236.612,422.712,828.712,828.7
+ Other Current Assets741.3679.41,449.31,449.3
Total Current Assets11,419.817,046.119,906.119,906.1
Total Assets29,280.837,201.752,406.652,406.6
Equity
+ Equity Share Capital100.6100.6100.6100.6
+ Other Equity / Reserves19,728.923,852.527,010.827,010.8
Equity — Owners of Parent19,829.523,953.127,111.427,111.4
+ Minority Interest2,272.12,405.32,470.82,470.8
Total Equity22,101.626,358.429,582.229,582.2
Liabilities
+ Borrowings — Non-current0.00.03,188.03,188.0
+ Other Non-current Financial Liab1,079.3904.31,744.71,744.7
Non-current Financial Liabilities1,079.3904.34,932.74,932.7
+ Provisions — Non-current309.7383.9445.3445.3
+ Deferred Tax Liabilities446.5512.61,734.01,734.0
+ Other Non-current Liabilities1.80.90.50.5
Non-current Liabilities1,837.31,801.77,112.57,112.5
+ Borrowings — Current768.63,169.58,581.58,581.5
+ Trade Payables2,126.72,305.82,845.12,845.1
+ Other Current Financial Liab1,399.62,232.92,962.82,962.8
Current Financial Liabilities4,294.97,708.214,389.414,389.4
+ Provisions — Current394.8451.4478.5478.5
+ Current Tax Liabilities372.0615.7366.3366.3
+ Other Current Liabilities278.0266.3477.7477.7
Current Liabilities5,339.79,041.615,711.915,711.9
Total Liabilities7,179.210,843.322,824.422,824.4
Total Equity & Liabilities29,280.837,201.752,406.652,406.6
Assets — additional as-filed lines
+ Non-current Assets Held for Sale81.60.00.00.0
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale2.20.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current97.4154.0154.0
+ Dues to Other Creditors — Current2,208.42,691.12,691.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.